Isaac Alonso-García

Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant <i>Pseudomonas aeruginosa</i>

Cristina Lasarte-Monterrubio, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha et al. · Journal of Antimicrobial Chemotherapy · 2022 · 53 citations

Life Sciences, Infectious Diseases, Microbiology +17

Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions

Tania Blanco-Martín, Isaac Alonso-García, Lucía González-Pinto et al. · International Journal of Antimicrobial Agents · 2024 · 31 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

Juan Carlos Vázquez-Ucha, Isaac Alonso-García, Paula Guijarro-Sánchez et al. · International Journal of Antimicrobial Agents · 2023 · 30 citations · Full text

Pharmacy, Pharmacology, Antimicrobial Pharmacotherapy +12

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against <i>Pseudomonas aeruginosa</i>

Lucía González-Pinto, Isaac Alonso-García, Tania Blanco-Martín et al. · Journal of Antimicrobial Chemotherapy · 2024 · 28 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

Eva Gato, Paula Guijarro-Sánchez, Isaac Alonso-García et al. · International Journal of Antimicrobial Agents · 2023 · 26 citations

Life Sciences, Infectious Diseases, Microbiology +16